Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.
van der Vries
Erhard
E
Stelma
Foekje F
FF
Boucher
Charles A B
CA
D019943:Amino Acid Substitution; D000998:Antiviral Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D004196:Disease Outbreaks; D024901:Drug Resistance, Multiple, Bacterial / Q000235:genetics*; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000235:genetics*; D007251:Influenza, Human / Q000188:drug therapy / Q000209:etiology / Q000821:virology*; D008297:Male; D009154:Mutation; D009439:Neuraminidase / Q000037:antagonists & inhibitors* / Q000235:genetics*; D053139:Oseltamivir / Q000627:therapeutic use; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications; D019562:Viral Load; D053243:Zanamivir / Q000627:therapeutic use
D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir